Cashing in on the Currency of Information

The Syneos Health Podcast

Medical science liaisons—or MSLs—within pharmaceutical companies deal in a special currency: scientific exchange and real-world insights gathering. Only they can share certain types of information with a growing number of medical stakeholders. And only they can bring back medical insights to guide strategic development and brand decisions. Yet, can anyone be certain that this highly valuable currency is being spent wisely?

Recently, some of our Medical Affairs experts led an engaging webinar on maximizing the value of your MSL team and driving better outcomes in pharmaceutical development.

Listen in as they unravel the challenges in quantifying MSLs’ value, explore how these teams are enhancing impact through strategic engagement, unpack new ways of measuring value beyond output and illustrate how companies can further empower MSLs with data-driven AI/tech-enabled solutions.

Be sure to check out these other insights from our Medical Affairs experts:

WEBINAR | From Insight to Impact: Leveraging Early Medical Affairs Engagement for Future Commercial Success

Driving Impact: Key Themes for Advancing Medical Affairs in the Evolving Pharma Landscape

Webinar | Driving Patient-Powered Medicine: Scientific Communication with Patient Communities

It’s Time We Got the Most Out of Medical Affairs Data

The views expressed in this podcast belong solely to the speakers and do not represent those of their organization.
If you want access to more future-focused, actionable insights to help biopharmaceutical companies better execute and succeed in a constantly evolving environment, visit the Syneos Health Insights Hub. The perspectives you’ll find there are driven by dynamic research and crafted by subject matter experts focused on real answers to help guide decision-making and investment. You can find it all at insightshub.health.
Like what you’re hearing? Be sure to rate and review us!
We want to hear from you! If there’s a topic you’d like us to cover on a future episode, contact us at [e-mail].